stockrow
Friday 6 November 2026
Export EMBC’s income statement to Excel — free account
Embecta Corp.
EMBC Healthcare Medical Instruments & Supplies
Embecta Corp.’s revenue for fiscal 2025 (year ended September 2025) was $1.1 billion, down 3.80% from fiscal 2024.
- Revenue
- −8.05%
- EPS
- −53.9%
- Free cash flow
- −49.6%
- Total debt
- −1.00%
Quarter to June 2026, against a year earlier
6.15
0.18
−2.84%
Follow EMBC
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 7 | 7 |
+8 more TTM periods Free account |
| (13.65%) | (16.43%) | (20.19%) | (13.74%) | ||
| 7.22% | 10.41% | 12.61% | 8.03% | ||
ROIC |
21.44% | 31.42% | 32.36% | 27.63% | |
Return on Tangible Assets |
14.53% | 18.70% | 21.99% | 15.21% | |
Average Days of Receivables |
65.28 | 51.50 | 53.82 | 49.19 | |
Free Cash Flow per Share |
2.99 | 3.62 | 3.67 | 3.13 | |
Free Cash Flow |
174.70 | 214.80 | 215.90 | 182.40 | |
Capital Expenditures |
0.60 | 1.30 | 1.70 | (9.30) | |
| Other line items | |||||
Cash ROIC |
16.06% | 23.31% | 21.99% | 18.15% | |
Accounts Receivable Turnover |
5.58 | 6.27 | 6.35 | 6.38 | |
Accounts Payable Turnover |
5.48 | 5.74 | 5.49 | 4.89 | |
Inventory Turnover |
2.07 | 2.20 | 2.27 | 2.31 | |
Average Days of Payables |
79.14 | 73.20 | 66.07 | 67.10 | |
Days of Inventory on Hand |
187.31 | 176.90 | 166.60 | 161.52 | |
Tax Rate |
(0.30) | (0.34) | (0.29) | (0.30) | |
Research and Development Expense of Revenue |
1.98% | 1.82% | 2.00% | 3.45% | |
Selling, General and Administrative Expense of Revenue |
31.34% | 31.18% | 30.43% | 30.73% | |
Share Based Compensation of Revenue |
2.48% | 2.59% | 2.65% | 2.92% | |
Interest Coverage |
2.31 | 2.70 | 2.87 | 2.26 | |
Operating CF/Net income |
1.99 | 1.91 | 1.54 | 2.01 | |
Depreciation/Fixed assets |
0.20 | 0.26 | 0.25 | 0.23 | |
Capex/Depreciation |
0.01 | 0.02 | 0.03 | (0.15) | |
Revenue per Share |
17.42 | 17.58 | 18.36 | 18.53 | |
Operating CF per Share |
2.98 | 3.60 | 3.64 | 3.29 | |
Capex per Share |
0.01 | 0.02 | 0.03 | (0.16) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 |
Columns are period end dates